Sepsis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Adrenomedullin has vascular properties and elevated plasma adrenomedullin levels were detected in sepsis.
|
31625979 |
2020 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
High plasma concentrations of ADM correlate with worse outcome in sepsis patients.
|
30782906 |
2019 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Adrenomedullin (ADM) is a vasoactive peptide in sepsis.
|
30822437 |
2019 |
Sepsis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Plasma levels of mid-regional pro-adrenomedullin in sepsis are associated with risk of death.
|
30207133 |
2019 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
ADM is strongly elevated in patients with sepsis and in patients with acute heart failure.
|
30592365 |
2019 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Circulating Biologically Active Adrenomedullin Predicts Organ Failure and Mortality in Sepsis.
|
31037864 |
2019 |
Sepsis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Compared to those of healthy individuals (n = 47), mRNA levels of ANG2, IL10, HBP, PCT, and ADM were increased in patients who eventually developed sepsis.
|
29413717 |
2018 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
The overall diagnostic accuracy of ADM and proADM in application to sepsis was pooled according to a bivariate model.
|
29246418 |
2018 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.
|
29246637 |
2018 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
In this review, we first provide a brief overview of the currently available data on the role of adrenomedullin in sepsis and describe its effects on endothelial barrier function and vasodilation.
|
29324626 |
2018 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Adrenomedullin (ADM) is an important regulator of endothelial barrier function and vascular tone, and may represent a novel treatment target in sepsis.
|
29856470 |
2018 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
<i>In vitro</i> and preclinical <i>in vivo</i> data show that administration of ADM exerts anti-inflammatory, antimicrobial, and protective effects on endothelial barrier function during sepsis, but other work suggests that it may also decrease blood pressure, which could be detrimental for patients with septic shock.
|
29520277 |
2018 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Finally, effects of single and repeated dose administration of HAM1101, HAM8101 and placebo on survival were assessed in CLP-induced murine sepsis (n = 60, n = 10 per group).
|
29324627 |
2018 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
In the present prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock 1 (, AdrenOSS-1) study, we assessed relationships between circulating bio-ADM during the initial intensive care unit (ICU) stay and short-term outcome in order to eventually design a biomarker-guided randomized controlled trial.
|
30583748 |
2018 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
The biological role of adrenomedullin (ADM), a hormone involved in hemodynamic homeostasis, is controversial in sepsis because administration of either the peptide or an antibody against it may be beneficial.
|
28411114 |
2017 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Adrenomedullin increased with severity (sepsis: 25.8 pg/mL [IQR 20.3-40.2], severe sepsis: 84.2 pg/mL [IQR 42.7-118.5], septic shock: 119.7 pg/mL [IQR 83.8-172.6]; P<.0001).
|
27865148 |
2017 |
Sepsis
|
0.600 |
Biomarker
|
disease |
RGD |
Human adrenomedullin and its binding protein ameliorate sepsis-induced organ injury and mortality in jaundiced rats.
|
20132852 |
2010 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
It remains unknown whether a combination of human AM and human AMBP-1 (AM/AMBP-1) is also beneficial in sepsis and, if so, whether human AM/AMBP-1 reverses established sepsis in rats.
|
19009024 |
2009 |
Sepsis
|
0.600 |
AlteredExpression
|
disease |
LHGDN |
Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis.
|
18080871 |
2008 |
Sepsis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Specifically, we find that certain conditions, such as pregnancy, cardiovascular disease, and sepsis, are associated with robust and dynamic changes in the expression of AM and AM receptor proteins, which together represent an elegant mechanism for altering the physiological responsiveness or function of AM.
|
17053041 |
2007 |
Sepsis
|
0.600 |
Biomarker
|
disease |
LHGDN |
Adrenomedullin and endothelial barrier function.
|
18000597 |
2007 |
Sepsis
|
0.600 |
AlteredExpression
|
disease |
LHGDN |
Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling.
|
17053041 |
2007 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Adrenomedullin (ADM) is a potent hypotensive peptide produced by macrophages and endothelial cells during ischemia and sepsis.
|
15930287 |
2005 |
Sepsis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Strong evidence now exists that AM is able to act as an autocrine, paracrine, or endocrine mediator in a number of biologically significant functions, including the endothelial regulation of blood pressure, protection against organ damage in sepsis or hypoxia, and the control of blood volume through the regulation of thirst.
|
15464589 |
2004 |
Sepsis
|
0.600 |
Biomarker
|
disease |
CTD_human |
Role of cyclooxygenase in ventricular effects of adrenomedullin: is adrenomedullin a double-edged sword in sepsis?
|
14766677 |
2004 |